Hayley C. Whitaker

Io Therapeutics (United States), University College London

Papers

2

Total Citations

6

H-Index

2

About

Dr. Hayley C. Whitaker is a translational researcher whose work bridges radiology and pathology to improve prostate cancer diagnosis and treatment. Her primary research focuses on optimizing tissue collection methodologies for prostate cancer research, particularly through the integration of magnetic resonance imaging (MRI) data to precisely target tumor and benign tissue in fresh radical prostatectomy specimens. Her landmark paper, "PEOPLE: PatiEnt prOstate samPlEs for rEsearch," established a standardized tissue collection pathway that has become foundational for prostate cancer biobanking, enabling more accurate molecular and histological analyses despite its recent publication. Dr. Whitaker also investigates the diagnostic potential of radiological markers, such as apical tumor involvement in prostate cancer staging. While her citation counts are still growing—reflecting the emerging nature of her work—her contributions are already shaping how researchers access and utilize high-quality prostate tissue for translational studies. Her efforts are critical for advancing personalized medicine in urological oncology, ensuring that downstream research into biomarkers and therapeutics is built on robust, clinically annotated specimens.

Research Focus

Key Achievements

2
H-Index
2
Papers
6
Total Citations
3
Avg Citations/Paper
🏆 Most Cited Paper
PEOPLE: PatiEnt prOstate samPLes for rEsearch, a tissue collection pathway utilizing magnetic resonance imaging data to target tumor and benign tissue in fresh radical prostatectomy specimens
4 citations · 2019
📈 Most Prolific Year: 2019 (1 Papers)
🤝 Key Collaborators: 31
🏛 Institutions: Io Therapeutics (United States), University College London

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago